The percentage on each card is AORT's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.
● Defense WorldNov 11, 2026 · 03:54 ETEARNINGS EXPECTED BY FEB 17
Financial Contrast: Zimmer Biomet (NYSE:ZBH) and Artivion (NYSE:AORT)
Zimmer Biomet (NYSE: ZBH - Get Free Report) and Artivion (NYSE: AORT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their p…
● MarketBeatNov 6, 2026 · 19:15 ETEARNINGS EXPECTED BY FEB 17
Artivion Q3 Earnings Call Highlights
Artivion NYSE: AORT reported 9% constant-currency revenue growth in the third quarter of 2026, while adjusted earnings declined as the medical device maker invested in manufacturing and prepared for the U.S. launch of it…
● Zacks Investment ResearchNov 5, 2026 · 18:46 ETEARNINGS EXPECTED BY FEB 17
Artivion (AORT) Lags Q3 Earnings Estimates
Artivion (AORT) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.16 per share a year ago.…
● PRNewsWireNov 5, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 17
Artivion Reports Third Quarter 2026 Financial Results
Third Quarter & Recent Business Highlights: Achieved revenue of $123.8 million in the third quarter of 2026 versus $113.4 million in the third quarter of 2025, an increase of 9% on a GAAP basis and 9% on a non-GAAP const…
● PRNewsWireOct 28, 2026 · 16:10 ETCOMPANY'S OWN WORDS
Artivion to Participate in Upcoming Investor Conferences
ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.…
● PRNewsWireOct 22, 2026 · 16:10 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 17
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
ATLANTA, Oct. 22, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2026 financial results will be released on …
Article counts from the last market-wide feed page, across every symbol we track and not just AORT · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.
The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.